Development
CME Group Inc.
CME
$271.29
$1.590.59%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 1.35B | 1.25B | 1.28B | 1.37B | 1.13B |
| Total Other Revenue | 85.10M | 82.20M | 76.40M | 73.20M | 70.80M |
| Total Revenue | 1.44B | 1.34B | 1.36B | 1.44B | 1.21B |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.44B | 1.34B | 1.36B | 1.44B | 1.21B |
| SG&A Expenses | 401.40M | 386.70M | 389.00M | 392.90M | 367.80M |
| Depreciation & Amortization | 86.30M | 88.30M | 89.30M | 88.70M | 90.60M |
| Other Operating Expenses | 63.30M | 40.10M | 40.90M | 43.90M | 91.90M |
| Total Operating Expenses | 551.00M | 515.10M | 519.20M | 525.50M | 550.30M |
| Operating Income | 885.80M | 820.20M | 838.60M | 913.70M | 655.10M |
| Income Before Tax | 1.01B | 974.30M | 1.02B | 1.16B | 827.30M |
| Income Tax Expenses | 191.40M | 224.10M | 238.80M | 273.10M | 189.40M |
| Earnings from Continuing Operations | 814.60M | 750.20M | 777.60M | 883.80M | 637.90M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 814.60M | 750.20M | 777.60M | 883.80M | 637.90M |
| EBIT | 885.80M | 820.20M | 838.60M | 913.70M | 655.10M |
| EBITDA | 972.10M | 908.50M | 927.90M | 1.00B | 745.70M |
| EPS Basic | 2.24 | 2.06 | 2.14 | 2.43 | 1.76 |
| Normalized Basic EPS | 1.75 | 1.70 | 1.77 | 2.01 | 1.44 |
| EPS Diluted | 2.24 | 2.06 | 2.14 | 2.43 | 1.76 |
| Normalized Diluted EPS | 1.75 | 1.69 | 1.77 | 2.01 | 1.44 |
| Average Basic Shares Outstanding | 359.20M | 359.02M | 358.94M | 358.93M | 358.89M |
| Average Diluted Shares Outstanding | 359.69M | 359.62M | 359.43M | 359.31M | 359.19M |
| Dividend Per Share | 1.10 | 1.10 | 1.10 | 1.10 | 1.00 |
| Payout Ratio | 49.12% | 53.32% | 51.41% | 230.32% | 56.98% |